financetom
Business
financetom
/
Business
/
Exclusive-MediaTek designs Arm-based chip for Microsoft's AI laptops, say sources
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-MediaTek designs Arm-based chip for Microsoft's AI laptops, say sources
Jun 11, 2024 1:16 PM

TAIPEI/SAN FRANCISCO (Reuters) - Taiwanese chip design giant MediaTek ( MDTTF ) is developing an Arm-based personal computer chip that will run Microsoft's ( MSFT ) Windows operating system, according to three people familiar with the matter.

Last month, Microsoft ( MSFT ) unveiled a new generation of laptops that feature chips designed with Arm Holdings tech which provide enough horsepower to run the artificial intelligence applications executives said were the future of consumer computing. The MediaTek ( MDTTF ) chip is geared toward this effort.

The software company's plans take aim at Apple ( AAPL ) which has released its own Arm-based chips for Mac computers for roughly four years. And Microsoft's ( MSFT ) decision to optimize Windows for Arm could threaten Intel's ( INTC ) longstanding dominance in the PC market. 

MediaTek ( MDTTF ) and Microsoft ( MSFT ) declined to comment.

The MediaTek PC chip is set to launch late next year after Qualcomm's ( QCOM ) exclusive deal to supply chips for laptops expires, two of the people said. The chip is based on Arm's ready-made designs, which can significantly speed development because less design work is needed using ready-made, tested chip components.

It was not immediately clear whether Microsoft ( MSFT ) has approved MediaTek's ( MDTTF ) PC chip for the Copilot+ Windows program.

Executives at Arm have said one of its customers used the ready-made components to build a chip in roughly nine months for a design that is already complete, which MediaTek's ( MDTTF ) is not. For experienced chip design businesses, advanced chips typically take considerably more than a year to construct and test, depending on the complexity.

In 2016, Microsoft ( MSFT ) tapped Qualcomm ( QCOM ) to spearhead moving the Windows operating system to Arm's underlying processor architecture, which has long powered smartphones and their small batteries. Microsoft ( MSFT ) granted Qualcomm ( QCOM ) an exclusivity arrangement to develop Arm-based Windows-compatible chips until 2024, Reuters reported last year.

Because the Qualcomm ( QCOM ) exclusivity arrangement with Microsoft ( MSFT ) is expiring, other designers have opted to build chips to help power Microsoft's ( MSFT ) latest push to use Arm designs. For decades, Windows machines have relied on chip architecture made by Advanced Micro Devices and Intel ( INTC ).

Nvidia ( NVDA ) and AMD are working on Arm designs for Windows machines, Reuters reported last year. The Nvidia ( NVDA ) effort for its PC chip involves help from MediaTek ( MDTTF ), according to a person familiar with the matter. The MediaTek ( MDTTF ) effort for a PC chip is separate from its collaboration with Nvidia ( NVDA ), two of the people said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CrowdStrike Shares Fall 6% Despite Beating Q3 Estimates: What's Going On?
CrowdStrike Shares Fall 6% Despite Beating Q3 Estimates: What's Going On?
Nov 27, 2024
Shares of CrowdStrike Holdings Inc. ( CRWD ) dropped by 6.14% in pre-market trading on Wednesday, according to Benzinga Pro. This decline followed a weaker-than-anticipated earnings forecast for the upcoming quarter, despite the company surpassing Wall Street estimates for the third quarter. What Happened: CrowdStrike projected adjusted earnings of $0.84 to $0.86 per share for the fiscal fourth quarter, missing Wall Street’s expectation of $$0.86 cents per...
Outlook Therapeutics Says Eye Disease Drug Fails Key Trial Endpoint; Shares Plunge
Outlook Therapeutics Says Eye Disease Drug Fails Key Trial Endpoint; Shares Plunge
Nov 27, 2024
07:31 AM EST, 11/27/2024 (MT Newswires) -- Outlook Therapeutics ( OTLK ) said Wednesday preliminary results from the second of two clinical trials evaluating its experimental drug, ONS-5010, an opthalmic formulation of bevacizumab in wet age-related macular degeneration patients, did not meet the pre-specified non-inferiority endpoint in the special protocol assessment with the US Food and Drug Administration. Shares of...
German cabinet approves measures for better access to capital markets
German cabinet approves measures for better access to capital markets
Nov 27, 2024
BERLIN (Reuters) - The German cabinet on Wednesday approved a package of measures to promote startups and improve access to capital markets, government sources told Reuters, though it is unclear whether it will also be green-lit by parliament before February elections. The so-called Second Financing for the Future Act is intended in particular to improve the tax framework for investments...
Symbotic Delays Fiscal 2024 Annual Report, Lowers Fiscal Q1 Revenue Outlook; Shares Fall
Symbotic Delays Fiscal 2024 Annual Report, Lowers Fiscal Q1 Revenue Outlook; Shares Fall
Nov 27, 2024
07:33 AM EST, 11/27/2024 (MT Newswires) -- Symbotic ( SYM ) said Wednesday it has submitted a notification of late filing for its annual report for the fiscal year ending Sept. 28, 2024, saying it needs more time to assess and correct an error related to revenue recognition and the impact of that error on its financial reporting. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved